Word

GLYCOTOPE

Status

Dead

Status Code

602

Status Date

Friday, August 21, 2015

Serial Number

85246561

Mark Type

3000

Filing Date

Friday, February 18, 2011

Published for Opposition

Tuesday, November 1, 2011

Abandoned Date

Friday, July 24, 2015

Trademark Owner History

Glycotope GmbH - Owner At Publication

Classifications

1 Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry, except fungicides, herbicides, insecticides and parasiticides; unprocessed artificial resins; unprocessed plastics; fertilising preparations; fire extinguishing compositions; tempering substances and soldering chemicals; chemical substances for fermenting and preserving food stuffs; tanning agents for use in the manufacture of leather; adhesives used in industry; bacteria and cell preparations and elements, fragments, fractions and lysates thereof, except for medical or veterinary purposes, namely, for use in protein production, food manufacturing, scientific research, waste water treatment, bacteria and cell preparations for use in expression of engineered or glycosylated proteins and peptides; preparations containing bacteria and cells, except for medical or veterinary purposes, namely, for use in protein production, food manufacturing, scientific research, waste water treatment; biological preparations for laboratories, except for medical or veterinary purposes, namely, for use in bacterial and cell engineering, cultivation, harvesting, protein production; chemical preparations for analysis in laboratories, namely, preparations for protein, peptide, engineered proteins and peptides, glycoproteins, glycosylation, antibody or antigen analysis, preparations comprising antibody reagents used for the detection of antigens; chemical preparations for scientific purposes; chemical reagents except for medical or veterinary purposes and biological reagents in the nature of reagents for use in protein production, bacterial and cell engineering, cultivation and harvesting, probes for detecting and analyzing molecules in protein or nucleotide arrays, except for medical or veterinary purposes; diagnostic preparations, except for medical or veterinary purposes; enzymes, proteins and related preparations for industrial purposes, namely, engineered proteins, glycosylated proteins, antibodies, enzymes for use in glycosylation, enzyme substrates, proteins used in the manufacture of cosmetics, beverages, food products and food supplements; ferments for chemical purposes, namely, yeast, bacterium, mold, or enzyme, that causes fermentation; in-vitro diagnostic reagents, other than for medical purposes, namely, for use in biochemistry, clinical chemistry and microbiology; carbohydrates for use in the manufacture of food or nutraceuticals; cultures of microorganisms, other than for medical or veterinary use, and cells and elements, fragments, fractions and lysates thereof, other than for medical or veterinary purposes, namely, cultures of microorganisms or cells other than for medical and veterinary use, microorganism or cell cultures for use in protein production, food manufacturing, scientific research, waste water treatment, cultures of microorganisms or cells for use in expression of proteins and peptides; expression systems for proteins and peptides comprising cells, particularly human cells and microorganisms, suitable for expressing engineered or glycosylated proteins or peptides, or capable of providing optimized glycosylation activity; milk ferments for chemical purposes

5 Pharmaceutical preparations and veterinary preparations for pets and livestock, namely, all for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; sanitary preparations for medical purposes; dietetic sugar for medical use; food for babies; medical plasters; materials for dressings, namely, wound dressings, burn dressings, and surgery dressings; materials for dental filling, namely, fillings for teeth, and impression materials for dental purposes; disinfectants for hygienic purposes, medical instruments, sanitary purposes; preparations for destroying vermin; fungicides, herbicides; adjuvants for medical purposes; medicines for human purposes and veterinary purposes for pets and livestock, namely, all for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; biological preparations for medical purposes; dietetic food adapted for medical purposes; enzymes, proteins, antibodies, cells, microorganisms as well as fragments, fractions, elements and lysates thereof for medical purposes for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine, and as nutritional additives for medical purposes for use in foods and dietary supplements for human consumption; vaccines; nutritional supplements, namely, carbohydrates for medical purposes, namely, for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; cultures of microorganisms for medical or veterinary purposes; cultures of cells, particularly human cells for medical or veterinary purposes; medicinal drinks; microorganisms, cells and preparations containing elements, fragments, fractions and lysates of microorganisms or cells for medical and veterinary purposes, namely, for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; biological therapeutics, namely, therapeutics containing cells, microorganisms, proteins, glycoproteins, peptides, glycopeptides or modified or conjugated versions thereof, all for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; milk ferments for pharmaceutical purposes, namely, for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; nutritional additives and nutritional supplement additives all for medical purposes for use in foods and dietary supplements for human consumption; nutrients for medical purposes, namely, nutritional supplements; sugar and carbohydrates for medical purposes, namely, therapeutically and prophylactically active sugar and carbohydrates, dietetic sugar and carbohydrates, sugar and carbohydrate replacements

42 Medical laboratories, namely, consumer-authorized clinical laboratory testing services that report results directly to the patient; scientific and technological services and research and designer services relating thereto, namely, in the field of biotechnology, protein production, glycosylation, optimization of protein, antibody and enzyme activity, bacteria and cell engineering, cultivation and harvesting; industrial analysis and research services in the field of biotechnology, protein production, glycosylation, protein, antibody and enzyme activity, bacteria and cell engineering, cultivation and harvesting; design and development of computer hardware and software; biological research; services of a chemical or biological laboratory; technical surveying; conducting scientific surveys in the field of biotechnology, bacterial and cell engineering, protein production, glycosylation; scientific research and development, namely, in the field of bacteriology, cytology, antibody technology, chemistry, immunology, cosmetics of expression systems in the nature of production or glycosylation of proteins, peptides, antibodies and enzymes, particularly for proteins and peptides; quality control for others; research and development of new products; research and development of new technologies for others in the field of biotechnology, protein production, glycosylation, protein, antibody and enzyme activity, bacteria and cell engineering, cultivation and harvesting; technical and scientific consultancy in relation to biotechnology, protein production, glycosylation, protein, antibody and enzyme activity, bacteria and cell engineering, cultivation and harvesting; research and development in the field of glycomics, expression systems in the nature of production or glycosylation of proteins, peptides, antibodies and enzymes, development and improvement of cells, cell lines and microorganisms, antibody-engineering, optimized biological therapeutics, nutraceuticals, food and nutritional supplements; scientific research, quality control, technical consultancy and product development in the field of proteins, antibodies, microorganisms and cells; scientific research and development in the field of microorganisms and cells

44 Medical services and veterinary services; hygienic and beauty care for human beings and animals; agriculture, horticulture and forestry services, namely, vermin extermination for agriculture, pest control services for agriculture, horticulture or forestry; pharmaceutical advice; performance of medical services featuring clinical examinations; nutrition counseling; health consultancy

Color is not claimed as a feature of the mark.
The mark consists of the word "GLYCOTOPE" in which the "O"s are shaded and have a vertical line above and below.

Trademark Events

Aug 21, 2015

Abandonment Notice Mailed - Failure To Respond

Aug 21, 2015

Abandonment - Failure To Respond Or Late Response

Jan 31, 2015

Assigned To Examiner

Jan 23, 2015

Notification Of Non-Final Action E-Mailed

Jan 23, 2015

Non-Final Action E-Mailed

Jan 23, 2015

Non-Final Action Written

Jan 22, 2015

Assigned To Examiner

Jan 22, 2015

Previous Allowance Count Withdrawn

Jan 22, 2015

Assigned To Examiner

Dec 30, 2014

Case Returned To Examination

Dec 29, 2014

Notice Of Allowance Cancelled

Nov 26, 2014

Attorney Review/Decision On Amendment Required

Nov 26, 2014

Petition To Director - Change Basis - Granted

Nov 19, 2014

Assigned To Petition Staff

Nov 10, 2014

Teas Petition To Amend Basis Received

Jun 6, 2014

Notice Of Approval Of Extension Request E-Mailed

Jun 5, 2014

Extension 5 Granted

Jun 4, 2014

Extension 5 Filed

Jun 4, 2014

Teas Extension Received

Apr 10, 2014

Assigned To Examiner

Dec 10, 2013

Notice Of Approval Of Extension Request E-Mailed

Dec 9, 2013

Extension 4 Granted

Dec 5, 2013

Extension 4 Filed

Dec 5, 2013

Teas Extension Received

Jul 18, 2013

Notice Of Approval Of Extension Request E-Mailed

Jul 17, 2013

Extension 3 Granted

Jun 19, 2013

Extension 3 Filed

Jul 15, 2013

Case Assigned To Intent To Use Paralegal

Jun 19, 2013

Teas Extension Received

Dec 22, 2012

Notice Of Approval Of Extension Request E-Mailed

Dec 20, 2012

Extension 2 Granted

Dec 20, 2012

Extension 2 Filed

Dec 20, 2012

Teas Extension Received

Jun 23, 2012

Notice Of Approval Of Extension Request E-Mailed

Jun 21, 2012

Extension 1 Granted

Jun 21, 2012

Extension 1 Filed

Jun 21, 2012

Teas Extension Received

Dec 27, 2011

Noa E-Mailed - Sou Required From Applicant

Nov 1, 2011

Official Gazette Publication Confirmation E-Mailed

Nov 1, 2011

Published For Opposition

Sep 27, 2011

Law Office Publication Review Completed

Sep 26, 2011

Approved For Pub - Principal Register

Sep 24, 2011

Teas/Email Correspondence Entered

Sep 24, 2011

Correspondence Received In Law Office

Sep 6, 2011

Teas Response To Office Action Received

Jun 1, 2011

Notification Of Non-Final Action E-Mailed

Jun 1, 2011

Non-Final Action E-Mailed

Jun 1, 2011

Non-Final Action Written

May 19, 2011

Assigned To Examiner

May 12, 2011

Applicant Amendment Prior To Examination - Entered

May 4, 2011

Assigned To Lie

Apr 27, 2011

Teas Voluntary Amendment Received

Feb 24, 2011

New Application Office Supplied Data Entered In Tram

Feb 22, 2011

New Application Entered In Tram